Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2023-09-01
|
| Series: | Annals of Intensive Care |
| Online Access: | https://doi.org/10.1186/s13613-023-01194-x |
| _version_ | 1797451486072930304 |
|---|---|
| author | Sylvie Chevret Lila Bouadma Claire Dupuis Charles Burdet Jean‑Francois Timsit the COVIDICUS RCT group |
| author_facet | Sylvie Chevret Lila Bouadma Claire Dupuis Charles Burdet Jean‑Francois Timsit the COVIDICUS RCT group |
| author_sort | Sylvie Chevret |
| collection | DOAJ |
| first_indexed | 2024-03-09T14:55:21Z |
| format | Article |
| id | doaj.art-87e81b0310304455b1cd061191310410 |
| institution | Directory Open Access Journal |
| issn | 2110-5820 |
| language | English |
| last_indexed | 2024-03-09T14:55:21Z |
| publishDate | 2023-09-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | Annals of Intensive Care |
| spelling | doaj.art-87e81b0310304455b1cd0611913104102023-11-26T14:13:15ZengSpringerOpenAnnals of Intensive Care2110-58202023-09-011311110.1186/s13613-023-01194-xCorrection: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trialSylvie Chevret0Lila Bouadma1Claire Dupuis2Charles Burdet3Jean‑Francois Timsit4the COVIDICUS RCT groupECSTRRA, UMR 1153, Saint Louis Hospital, University Paris CitéMedical and Infectious Diseases ICU, APHP Bichat HospitalUniversité Paris Cité, IAME, INSERM, UMR 1137Université Paris Cité, IAME, INSERM, UMR 1137Medical and Infectious Diseases ICU, APHP Bichat Hospitalhttps://doi.org/10.1186/s13613-023-01194-x |
| spellingShingle | Sylvie Chevret Lila Bouadma Claire Dupuis Charles Burdet Jean‑Francois Timsit the COVIDICUS RCT group Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial Annals of Intensive Care |
| title | Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial |
| title_full | Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial |
| title_fullStr | Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial |
| title_full_unstemmed | Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial |
| title_short | Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial |
| title_sort | correction which severe covid 19 patients could benefit from high dose dexamethasone a bayesian post hoc reanalysis of the covidicus randomized clinical trial |
| url | https://doi.org/10.1186/s13613-023-01194-x |
| work_keys_str_mv | AT sylviechevret correctionwhichseverecovid19patientscouldbenefitfromhighdosedexamethasoneabayesianposthocreanalysisofthecovidicusrandomizedclinicaltrial AT lilabouadma correctionwhichseverecovid19patientscouldbenefitfromhighdosedexamethasoneabayesianposthocreanalysisofthecovidicusrandomizedclinicaltrial AT clairedupuis correctionwhichseverecovid19patientscouldbenefitfromhighdosedexamethasoneabayesianposthocreanalysisofthecovidicusrandomizedclinicaltrial AT charlesburdet correctionwhichseverecovid19patientscouldbenefitfromhighdosedexamethasoneabayesianposthocreanalysisofthecovidicusrandomizedclinicaltrial AT jeanfrancoistimsit correctionwhichseverecovid19patientscouldbenefitfromhighdosedexamethasoneabayesianposthocreanalysisofthecovidicusrandomizedclinicaltrial AT thecovidicusrctgroup correctionwhichseverecovid19patientscouldbenefitfromhighdosedexamethasoneabayesianposthocreanalysisofthecovidicusrandomizedclinicaltrial |